Henry Meds and Mounjaro: Tirzepatide, Brand vs Compounded

This PlexusDx Education Hub review examines the Mounjaro question specifically — branded tirzepatide versus what a telehealth program actually provides — and the genetics involved. Browse all Peptides & GLP-1 education.

Independent editorial review. PlexusDx has no commercial relationship with Henry Meds or with the makers of Mounjaro, and received no compensation for this article.

Full head-to-head: PlexusDx vs Henry Meds →

People searching “Henry Meds Mounjaro” usually want to know whether the program supplies that specific branded drug. This review answers that by separating the brand name from the molecule, explaining how Henry handles tirzepatide, and covering the metabolic genetics beneath it. Pricing is as verified July 20, 2026, and the framing is educational.

Mounjaro versus tirzepatide: naming the difference

Mounjaro is a brand name for tirzepatide, an FDA-approved product from its manufacturer. Tirzepatide is the underlying molecule, a dual GIP/GLP-1 receptor agonist. A compounded tirzepatide preparation is not Mounjaro, even though it shares the same active compound, because Mounjaro refers specifically to the approved branded product rather than the molecule in general.

Does Henry Meds offer Mounjaro?

Telehealth compounding programs in this model generally work with compounded tirzepatide rather than dispensing branded Mounjaro. As of July 2026, Henry offers tirzepatide only as oral dissolving tablets — it does not publish an injectable tirzepatide. Whether any branded product is available should be confirmed directly on Henry Meds’s official website before you assume it is.

Henry’s tirzepatide format: oral dissolving tablets

Henry’s tirzepatide is sold as a 3-month supply at $1,047 ($891 paid in full), with no published month-to-month rate (verified July 20, 2026). The rest of the ladder below provides context for how that sits against Henry’s other options.

• Injectable compounded semaglutide (the flagship): $297/month month-to-month. Prepaying lowers it — the 6-month plan runs $1,482 ($247/month) and the 12-month plan runs $2,364 ($197/month). The widely advertised “$197/month” is that 12-month prepaid-in-full rate, not a month-to-month price.
• Oral (sublingual) semaglutide: $249/month month-to-month, with a $179/month tier.
• Oral tirzepatide: dissolving tablets only — Henry does not offer an injectable tirzepatide as of July 2026. It is sold as a 3-month supply at $1,047 ($891 paid in full); there is no published month-to-month tirzepatide rate.
• Liraglutide (injectable): $179/month month-to-month.
• Phentermine (oral): $149/month.

The dual-agonist mechanism in brief

Tirzepatide is distinctive because it activates two incretin receptors — GIP and GLP-1 — rather than one. The tirzepatide weight-management evidence base includes the SURMOUNT program (NEJM 2022) and SURMOUNT-OSA (NEJM 2024). Trial populations and endpoints vary, and individual outcomes vary, which is why the molecule is prescribed by a clinician rather than selected off a menu.

The metabolic genetics tirzepatide acts on

A dual agonist engages more of the incretin system, but the terrain it engages — appetite set points, glucose handling — is written in your genes. TCF7L2 shapes glucose handling and GLP1R and MC4R govern the incretin and satiety signaling a dual agonist engages — the individual terrain that decides how tirzepatide’s two-receptor action plays out.

Engaging two receptors still means engaging your specific biology. PlexusDx runs its own Weight Management Protocols, offering Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection and Tirzepatide Oral — but it leads with the Precision Peptide Genetic Test, which reads 14 pathways, 49 peptides, 150+ genetic insights, including TCF7L2 and MC4R. Knowing that baseline first is what turns a prescription decision into an informed conversation with your provider.

Not affiliated: PlexusDx has no commercial relationship with Henry Meds or with the maker of Mounjaro, and this review was prepared independently.

Related reading on PlexusDx:Mounjaro For Hypertension, Mounjaro Subscription, Mounjaro vs Liraglutide, Mounjaro Side Effects.

For transparency: this article is educational and independent, and PlexusDx offers its own tirzepatide and semaglutide protocols. The Precision Peptide Genetic Test looks at peptide-related pathways and does not predict response to tirzepatide or any medication. Speak with a licensed provider before starting any protocol.

Before weighing tirzepatide, map your baseline: see the Weight Management Protocols, or take the Precision Peptide Genetic Test to understand your metabolic pathway first.

Frequently Asked Questions About Henry Meds and Mounjaro

Does Henry Meds sell Mounjaro?

Compounded telehealth programs typically provide compounded tirzepatide rather than the branded Mounjaro product. As of July 2026 Henry offers tirzepatide only as oral dissolving tablets and publishes no injectable version. Confirm directly on Henry’s official website whether any branded option is available before assuming it is offered.

Is compounded tirzepatide the same as Mounjaro?

They share the same active molecule but are not the same product. Mounjaro is the FDA-approved branded tirzepatide; a compounded version is prepared by a 503A pharmacy for an individual prescription. The distinction matters for regulatory pathway and sourcing, so discuss it with your provider before starting.

How is Henry’s tirzepatide priced?

As of July 20, 2026, Henry offers tirzepatide as oral dissolving tablets in a 3-month supply at $1,047, or $891 paid in full, with no month-to-month rate published. There is no injectable tirzepatide listed. Verify the current figures on Henry’s official website before relying on them.

Can a genetic test tell me if tirzepatide will work?

No. The Precision Peptide Genetic Test does not predict response to tirzepatide or any medication. It reads pathway variants such as TCF7L2 and MC4R that describe your glucose-handling and satiety biology — helpful context for a clinical conversation, not a forecast of any specific result.

This article lives in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.